Overview


According to FutureWise analysis the market for cell surface markers in 2023 is US$ 0.76 billion, and is expected to reach US$ 1.44 billion by 2031 at a CAGR of 8.3%.

Cell surface markers are unique proteins or carbohydrates linked to the cell membrane and expressed on the surface of cells and are frequently used to quickly identify a particular cell type. For instance, the differentiation process and lineage of T and B cells are identified by their surface markers. For various biological activities, these lymphocytes develop into diverse cell subtypes. While some proteins facilitate molecule transport across the membrane, cell surface markers also play a part in intercellular communication and identification. To categorize cells based on their markers, cell surface markers are utilized. From cancer cells to stem cells to cells carrying the HIV, many types of cells can be identified using this data. Additionally, cell surface markers are like a fingerprint—they are unique to each type of cell and can be recognized based on the markers present on the membrane.

Cell surface indicators could help with drug discovery, particularly in the area of personalized medicine, in addition to just cell identification. Scientists are starting to make strides in creating novel medications thanks to the capacity of cell surface markers to recognize individual cells based on their surface characteristics. It is anticipated that using technologies like flow cytometry to analyze cell surface markers will simplify the analysis of diseases, sample preparation, and disease diagnosis. Cell surface marker research is currently made possible by various assay methods that examine gene expression and regulation, genotyping, signal transduction, and epigenetic alteration. For the examination of cell surface markers, some of the most used tools are chromatin IP products, siRNA, miRNA, pathway reporters, mutation analysis, and PCR arrays.

FutureWise Market Research has published a report that provides an insightful analysis of cell surface markers market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the cell surface markers market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • Abcam
  • Qiagen N.V.
  • F. Hoffman-La Roche.
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Genscript
  • Biolegend
  • Cell Signaling Technology
  • Bio-Techne
  • Merk KGaA
  • Siemens Healthcare Private Limited
  • Beckman Coulter, Inc.
  • Nihon Kohden Corporation
  • Abbott
  • Cell Signaling Technology, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Cell Surface Markers Market:

In April 2022- CytoSMART Technologies, a division of Axion Bio, unveiled the CytoSMART Omni FL, a next-generation live-cell imaging analysis system that, for the first time, expands the acclaimed CytoSMART Omni product line to include red and green fluorescence channels. The innovation offers a cutting-edge platform for researchers in stem cell biology, immuno-oncology, virology, toxicology, neurology, and other fields. It also exemplifies the company's ongoing commitment to offering high-quality, reasonably priced live-cell imaging to every cell biology lab.

The demand for precision medicine increased diagnostic use, and technological advancements related to higher throughput and automation are the main drivers of the market's growth. Cell surface markers have been employed more frequently for prognosis, diagnosis, and treatment over the last few decades. It's critical to look at biomarkers in cancer patients before and after treatment to pinpoint certain cell types that increase the chance of the disease's onset and subsequent post-treatment relapse. Also, cell surface markers, including CD3, CD4, CD8, and CD25, are frequently utilized to distinguish between cytotoxic, helper, and regulatory T cell subtypes in T cells. The presence and quantity of specific cell types in a sample can influence selection for clinical trials, the creation of new treatments, and many other considerations. The vast application of markers is anticipated to propel the market growth. Furthermore, the creation of novel products also helps the market expand. For instance, a lot of historically labor-intensive and manually handled activities can be automated to speed up laboratory workflow. The industries in this sector are always refining their products and releasing newer, more complex ones that are precise and effective. This is due to technological advancements and the scaling back of many devices and technologies used in the healthcare industry. However, many clinical laboratories are reluctant to invest in sophisticated cell marker analysis equipment because of the technology's complexity and high cost and the concurrent uncertainty surrounding the regulation and reimbursement for cell marker diagnostic procedures. The unwillingness to invest extensively in sophisticated models is expected to impede market expansion.

By Product

  • Antibodies
  • PCR Arrays

By Source

  • Mice
  • Rats
  • Other Sources

By Application

  • Research Applications
    •  Drug Discovery
    •  Immunology
    •  Stem Cell Research
    •  Other Research Applications
  • Clinical Applications
    •  Oncology
    • Immunodeficiency Diseases
    •  Other Clinical Applications

 By Cell Type

  • T Cell Surface Markers
  • B Cell Surface Markers
  • NK Cell Surface Markers
  • Monocyte Cell Surface Markers
  • Other Cell Types

By End User

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The main causes of the sizeable market share are the presence of the biotech industry, rapidly expanding applications in illness diagnostics, and the existence of reputable research organizations. The expansion of government R&D projects facilitates market expansion. Major market players' presence and their important strategies, like alliances and collaborations, are further driving the industry's expansion. For instance, in September 2021, Screen Holdings Co., Ltd. and PHC Corporation of North America agreed to offer the Screen Cell Imager series of cell imaging equipment in North America. The BD FACSymphony A1 Cell Analyzer, a new benchtop cell analyzer, was introduced by Becton, Dickinson, and Company in August 2021. The fluorescence-activated cell analyzer is anticipated to give laboratories of all sizes powerful flow cytometry capabilities. Over the forecast period, this development is anticipated to fuel market expansion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Cell Surface Markers Market By Product, By Source, By Application, By Cell Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Sourceology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Cell Surface Markers Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cell Surface Markers Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Cell Surface Markers Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Cell Surface Markers Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Antibodies
        2. Pcr Arrays

  • 8.   Global Cell Surface Markers Market, By Source Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Mice
        2. Rats
        3. Other Sources

  • 9.   Global Cell Surface Markers Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Applications
         1.1. Drug Discovery
         1.2. Immunology
         1.3. Stem Cell Research
         1.4. Other Research Applications
        2. Clinical Applications
         2.1. Oncology
         2.2. Immunodeficiency Diseases
         2.3. Other Clinical Applications

  • 10.   Global Cell Surface Markers Market, By Cell Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. T Cell Surface Markers
        2. B Cell Surface Markers
        3. NK Cell Surface Markers
        4. Monocyte Cell Surface Markers
        5. Other Cell Types

  • 11.   Global Cell Surface Markers Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic and Research Institutes
        2. Hospitals and Clinical Testing Laboratories
        3. Pharmaceutical and Biotechnology Companies

  • 12.   North America Cell Surface Markers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Cell Surface Markers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Cell Surface Markers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Cell Surface Markers Market Analysis 2017-2022 and Forecast 2023-2031(USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton, Dickinson and Company
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abcam
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Qiagen N.V.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. F. Hoffman-La Roche.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Danaher Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Genscript
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Biolegend
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cell Signaling Technology
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Bio-Techne
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Merk KGaA
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Siemens Healthcare Private Limited
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Beckman Coulter, Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Nihon Kohden Corporation
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Abbott
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Cell Signaling Technology, Inc.
         17.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients